Elsevier

Epilepsy Research

Volume 16, Issue 2, October 1993, Pages 89-98
Epilepsy Research

Research report
Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons

https://doi.org/10.1016/0920-1211(93)90023-ZGet rights and content

Abstract

Gabapentin (GBP) is a cyclic γ-aminobutyric acid (GABA) analog and investigational antiepileptic drug which is effective in the treatment of a variety of human and experimental seizures. GBP's antiepileptic mechanism of action is not known. The present studies tested for effects of GBP on inhibitory (GABA and glycine) and excitatory (N-methyl-d-aspartate (NMDA) and non-NMDA) amino acid neurotransmitter receptors, on repetitive firing of sodium (Na+) action potentials, and on voltage-dependent calcium (Ca2+) channel currents in cultured rodent neurons using intracellular, whole cell, or single channel recording techniques. GBP did not have a significant effect in any experiment when tested at or above concentrations that are therapeutic in humans except for a variable enhancement of NMDA-evoked depolarizations. These results suggest that the antiepileptic activity of GBP is not due to direct effects at receptors for inhibitory or excitatory amino acids or on voltage-dependent Na+ or Ca2+ channels.

References (29)

  • G. Bauer et al.

    Gabapentin in the treatment of drug-resistant epileptic patients

    Adv. Epileptol.

    (1989)
  • D. Chadwick

    Gabapentin

  • P. Crawford et al.

    Gabapentin as an antiepileptic drug in man

    J. Neurol. Neurosurg. Psychiatry

    (1987)
  • D.J. Dooley et al.

    Preclinical characterization of the anticonvulsant gabapentin

  • Cited by (0)

    View full text